Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?. (May 2014)

• Record Type: Journal Article
• Authors: Romero, Roberto; Yoon, Bo Hyun; Chaemsaithong, Piya; Cortez, Josef; Park, Chan-Wook; Gonzalez, Rogelio; Behnke, Ernesto; Hassan, Sonia S.; Chaiworapongsa, Tinnakorn; Yeo, Lami
• Is Part Of: Journal of maternal-fetal & neonatal medicine. Volume 27:Number 8(2014:Aug.)
• Page Start: 775
• Page End: 788
• Publication Date: 2014-05
• Subjects: Obstetrics -- Periodicals; Perinatology -- Periodicals; Infants (Newborn) -- Diseases -- Periodicals; Neonatology -- Periodicals; 618.2
• DOI: 10.3109/14767058.2013.844124
• Languages: English
• ISSNs: 1476-7058

Abstract

<abstract> <title>Abstract</title> <p> <italic>Background</italic>: Meconium-stained amniotic fluid (MSAF) is a common occurrence among women in spontaneous labor at term, and has been associated with adverse outcomes in both mother and neonate. MSAF is a risk factor for microbial invasion of the amniotic cavity (MIAC) and preterm birth among women with preterm labor and intact membranes. We now report the frequency of MIAC and the presence of bacterial endotoxin in the amniotic fluid of patients with MSAF at term.</p> <p> <italic>Materials and methods</italic>: We conducted a cross-sectional study including women in presumed preterm labor because of uncertain dates who underwent amniocentesis, and were later determined to be at term (<italic>n</italic> = 108). Patients were allocated into two groups: (1) MSAF (<italic>n</italic> = 66) and (2) clear amniotic fluid (<italic>n</italic> = 42). The presence of bacteria was determined by microbiologic techniques, and endotoxin was detected using the Limulus amebocyte lysate (LAL) gel clot assay. Statistical analyses were performed to test for normality and bivariate comparisons.</p> <p> <italic>Results</italic>: Bacteria were more frequently present in patients with MSAF compared to those with clear amniotic fluid [19.6% (13/66) versus 4.7% (2/42); <italic>p</italic> < 0.05]. The microorganisms were Gram-negative rods (<italic>n</italic> = 7), <italic>Ureaplasma urealyticum</italic> (<italic>n</italic> = 4), Gram-positive rods (<italic>n</italic> = 2) and <italic>Mycoplasma hominis</italic> (<italic>n</italic> = 1). The LAL gel clot assay was positive in 46.9% (31/66) of patients with MSAF, and in 4.7% (2/42) of those with clear amniotic fluid (<italic>p</italic> < 0.001). After heat treatment, the frequency of a positive LAL gel clot assay remained higher in the MSAF group [18.1% (12/66) versus 2.3% (1/42), <italic>p</italic> < 0.05]. Median amniotic fluid IL-6 concentration (ng/mL) was higher [1.3 (0.7–1.9) versus 0.6 (0.3–1.2), <italic>p</italic> = 0.04], and median amniotic fluid glucose concentration (mg/dL) was lower [6 (0–8.9) versus 9 (7.4–12.6), <italic>p</italic> < 0.001] in the MSAF group, than in those with clear amniotic fluid.</p> <p> <italic>Conclusion</italic>: MSAF at term was associated with an increased incidence of MIAC. The index of suspicion for an infection-related process in postpartum women and their neonates should be increased in the presence of MSAF.</p> </abstract>